TP, V., A, P., Z, M., A, L., MK, A., & SG, P. (2025). Re: Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience. Hematological oncology, 43(5), e70123. https://doi.org/10.1002/hon.70123
Chicago Style (17th ed.) CitationTP, Vassilakopoulos, Piperidou A, Mellios Z, Liaskas A, Angelopoulou MK, and Papageorgiou SG. "Re: Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience." Hematological Oncology 43, no. 5 (2025): e70123. https://doi.org/10.1002/hon.70123.
MLA (9th ed.) CitationTP, Vassilakopoulos, et al. "Re: Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience." Hematological Oncology, vol. 43, no. 5, 2025, p. e70123, https://doi.org/10.1002/hon.70123.